Noven will keep its name and remain at its current New York and Miami locations with its existing staff after its purchase by Hisamitsu Pharmaceutical Co. Hisamitsu will buy Noven for $16.50 per share which is a 22.4 percent premium on Noven stock"s most recent closing price.
저작권자 © 메디칼업저버 무단전재 및 재배포 금지